Kinnate Biopharma Inc. EBITDA 2021-2023 | KNTE
Kinnate Biopharma Inc. ebitda from 2021 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Kinnate Biopharma Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-125 |
| 2022 | $-117 |
| 2021 | $-88 |
| 2020 | $-36 |
| 2019 | $-12 |
| 2018 | $-8 |
| Kinnate Biopharma Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-12-31 | $-20 |
| 2023-09-30 | $-34 |
| 2023-06-30 | $-35 |
| 2023-03-31 | $-35 |
| 2022-12-31 | $-33 |
| 2022-09-30 | $-31 |
| 2022-06-30 | $-27 |
| 2022-03-31 | $-27 |
| 2021-12-31 | $-26 |
| 2021-09-30 | $-24 |
| 2021-06-30 | $-21 |
| 2021-03-31 | $-17 |
| 2020-12-31 | $-14 |
| 2020-09-30 | $-10 |
| 2020-06-30 | $-8 |
| 2020-03-31 | $-4 |
